Simona Denkovski
Family · Sterling Heights, MINPI 1699496398
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 515 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Amgen at 25.1% of the total. 2025 is the largest year on record at $4,200, more than ten times the $163 reported in 2022. Among family clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 515 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$2K
- Johnson & Johnson$2K
- UCB, Inc.$902
- Novartis$806
- Lilly USA, LLC$537
- plus $3K from 17 others
What the payments were for
- Food & beverage$10,50097%
- Education$3483%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 158 | $2,719 |
| AbbVie | 77 | $1,770 |
| Johnson & Johnson | 64 | $1,594 |
| UCB, Inc. | 45 | $902 |
| Novartis | 40 | $806 |
| Lilly USA, LLC | 21 | $537 |
| Pfizer | 29 | $493 |
| ANI Pharmaceuticals, Inc. | 14 | $301 |
| GSK | 7 | $225 |
| Sanofi | 14 | $214 |
| Janssen Scientific Affairs, LLC | 2 | $180 |
| E.r. Squibb & Sons, L.L.C. | 7 | $170 |
| AstraZeneca(2 entities) | 7 | $169 |
| Fresenius Kabi USA, LLC | 5 | $160 |
| Aurinia Pharma U.S., Inc. | 7 | $140 |
| Organon | 6 | $136 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $116 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $102 |
| Genentech USA, Inc. | 1 | $29 |
| Radius Health, Inc. | 1 | $25 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,848 in reported general payments places this provider in the 95th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 72 | $561,719 |
| Humira(Cf) PenAdalimumab | 40 | $269,998 |
| RinvoqUpadacitinib | 35 | $214,240 |
| Cosentyx Unoready PenSecukinumab | 13 | $104,324 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $82,151 |
| ActemraTocilizumab | 14 | $65,276 |
| Hydroxychloroquine Sulfate | 153 | $8,933 |
| MethotrexateMethotrexate Sodium | 159 | $6,091 |
| Leflunomide | 43 | $2,421 |
| Prednisone | 271 | $2,256 |
| Duloxetine Hcl | 66 | $1,153 |
| Azathioprine | 17 | $910 |
| Mycophenolate Mofetil | 11 | $786 |
| Pregabalin | 33 | $769 |
| Colchicine | 31 | $653 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $1,770 | $214,24035 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,657 family providers in Michigan.
Other family in Sterling Heights
- Brittany SharpSterling Heights$10K
- Darlene BrownSterling Heights$9K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.